A citation-based method for searching scientific literature

Christopher M Dillingham, Michal M Milczarek, James C Perry, Seralynne D Vann. Neurosci Biobehav Rev 2021
Times Cited: 4







List of co-cited articles
1 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity




Atrophy of the ipsilateral mammillary body in unilateral hippocampal sclerosis shown by thin-slice-reconstructed volumetric analysis.
Yohei Morishita, Shunji Mugikura, Naoko Mori, Hajime Tamura, Shiho Sato, Toshiaki Akashi, Kazutaka Jin, Nobukazu Nakasato, Kei Takase. Neuroradiology 2019
4
25


Interrater reliability of a method to assess hypothalamic involvement in pediatric adamantinomatous craniopharyngioma.
Ros Whelan, Eric Prince, David M Mirsky, Robert Naftel, Aashim Bhatia, Benedetta Pettorini, Shivaram Avula, Susan Staulcup, Allyson L Alexander, Maxene Meier,[...]. J Neurosurg Pediatr 2019
5
25


The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss.
Anna Secher, Jacob Jelsing, Arian F Baquero, Jacob Hecksher-Sørensen, Michael A Cowley, Louise S Dalbøge, Gitte Hansen, Kevin L Grove, Charles Pyke, Kirsten Raun,[...]. J Clin Invest 2014
386
25

Treatment of hypothalamic obesity with caffeine and ephedrine.
Frank L Greenway, George A Bray. Endocr Pract 2008
26
25

GLP-1 receptor activation modulates appetite- and reward-related brain areas in humans.
Liselotte van Bloemendaal, Richard G IJzerman, Jennifer S Ten Kulve, Frederik Barkhof, Robert J Konrad, Madeleine L Drent, Dick J Veltman, Michaela Diamant. Diabetes 2014
168
25

GLP-1 and estrogen conjugate acts in the supramammillary nucleus to reduce food-reward and body weight.
Heike Vogel, Stefanie Wolf, Cristina Rabasa, Francisca Rodriguez-Pacheco, Carina S Babaei, Franziska Stöber, Jürgen Goldschmidt, Richard D DiMarchi, Brian Finan, Matthias H Tschöp,[...]. Neuropharmacology 2016
39
25

GLP-1 receptors exist in the parietal cortex, hypothalamus and medulla of human brains and the GLP-1 analogue liraglutide alters brain activity related to highly desirable food cues in individuals with diabetes: a crossover, randomised, placebo-controlled trial.
Olivia M Farr, Michail Sofopoulos, Michael A Tsoukas, Fadime Dincer, Bindiya Thakkar, Ayse Sahin-Efe, Andreas Filippaios, Jennifer Bowers, Alexandra Srnka, Anna Gavrieli,[...]. Diabetologia 2016
101
25

Glucagon-like peptide 1 (GLP-1) and eating.
Jean-Pierre Gutzwiller, Lukas Degen, Ludwig Heuss, Christoph Beglinger. Physiol Behav 2004
31
25

Obesity in childhood craniopharyngioma: relation to post-operative hypothalamic damage shown by magnetic resonance imaging.
C J de Vile, D B Grant, R D Hayward, B E Kendall, B G Neville, R Stanhope. J Clin Endocrinol Metab 1996
147
25

Dexamphetamine use for management of obesity and hypersomnolence following hypothalamic injury.
D Ismail, M A O'Connell, M R Zacharin. J Pediatr Endocrinol Metab 2006
37
25

Pediatric craniopharyngiomas: classification and treatment according to the degree of hypothalamic involvement.
Stéphanie Puget, Matthew Garnett, Alison Wray, Jacques Grill, Jean-Louis Habrand, Nathalie Bodaert, Michel Zerah, Mercia Bezerra, Dominique Renier, Alain Pierre-Kahn,[...]. J Neurosurg 2007
240
25

The mammillary bodies and memory: more than a hippocampal relay.
Seralynne D Vann, Andrew J D Nelson. Prog Brain Res 2015
62
25

Mammillary body changes and seizure outcome after laser interstitial thermal therapy of the mesial temporal lobe.
Sanjeet S Grewal, Vivek Gupta, Prasanna Vibhute, Jerry J Shih, William O Tatum, Robert E Wharen. Epilepsy Res 2018
8
25

Post-operative hypothalamic lesions and obesity in childhood craniopharyngioma: results of the multinational prospective trial KRANIOPHARYNGEOM 2000 after 3-year follow-up.
Hermann L Müller, Ursel Gebhardt, Carmen Teske, Andreas Faldum, Isabella Zwiener, Monika Warmuth-Metz, Torsten Pietsch, Fabian Pohl, Niels Sörensen, Gabriele Calaminus. Eur J Endocrinol 2011
145
25


Impact sibutramine therapy in children with hypothalamic obesity or obesity with aggravating syndromes.
Pernilla Danielsson, Annika Janson, Svante Norgren, Claude Marcus. J Clin Endocrinol Metab 2007
54
25

Hypothalamic Obesity following Craniopharyngioma Surgery: Results of a Pilot Trial of Combined Diazoxide and Metformin Therapy.
Jill K Hamilton, Louise S Conwell, Catriona Syme, Alexandra Ahmet, Allison Jeffery, Denis Daneman. Int J Pediatr Endocrinol 2011
53
25


Semiquantitative analysis of hypothalamic damage on MRI predicts risk for hypothalamic obesity.
Christian L Roth, Hedieh Eslamy, David Werny, Clinton Elfers, Michele L Shaffer, Catherine Pihoker, Jeffrey Ojemann, William B Dobyns. Obesity (Silver Spring) 2015
48
25

A randomized, placebo-controlled trial of beloranib for the treatment of hypothalamic injury-associated obesity.
Ashley Shoemaker, Joseph Proietto, M Jennifer Abuzzahab, Tania Markovic, Jaret Malloy, Dennis D Kim. Diabetes Obes Metab 2017
14
25

Memory and the region of the mammillary bodies.
V Sziklas, M Petrides. Prog Neurobiol 1998
72
25

CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009.
Therese A Dolecek, Jennifer M Propp, Nancy E Stroup, Carol Kruchko. Neuro Oncol 2012
25

Projections from the hippocampal region to the mammillary bodies in macaque monkeys.
John P Aggleton, Seralynne D Vann, Richard C Saunders. Eur J Neurosci 2005
64
25

GLP-1 modulates the supramammillary nucleus-lateral hypothalamic neurocircuit to control ingestive and motivated behavior in a sex divergent manner.
Lorena López-Ferreras, Kim Eerola, Devesh Mishra, Olesya T Shevchouk, Jennifer E Richard, Fredrik H Nilsson, Matthew R Hayes, Karolina P Skibicka. Mol Metab 2019
11
25

Risk score for the prediction of severe obesity in pediatric craniopharyngiomas: relative to tumor origin.
Danling Li, Jun Pan, Junxiang Peng, Shichao Zhang, Guanglong Huang, Xi'an Zhang, Yun Bao, Songtao Qi. Pediatr Res 2018
5
25

GLP-1 and weight loss: unraveling the diverse neural circuitry.
Scott E Kanoski, Matthew R Hayes, Karolina P Skibicka. Am J Physiol Regul Integr Comp Physiol 2016
101
25

Gut feeling--the secret of satiety?
Steve Bloom, Katie Wynne, Owais Chaudhri. Clin Med (Lond) 2005
10
25

A phase 3 randomized clinical trial using a once-weekly glucagon-like peptide-1 receptor agonist in adolescents and young adults with hypothalamic obesity.
Christian L Roth, Francisco A Perez, Kathryn B Whitlock, Clinton Elfers, Jack A Yanovski, Ashley H Shoemaker, M Jennifer Abuzzahab. Diabetes Obes Metab 2021
5
25

Excess mortality and morbidity in patients with craniopharyngioma, especially in patients with childhood onset: a population-based study in Sweden.
Daniel S Olsson, Eva Andersson, Ing-Liss Bryngelsson, Anna G Nilsson, Gudmundur Johannsson. J Clin Endocrinol Metab 2015
87
25

Longitudinal study on growth and body mass index before and after diagnosis of childhood craniopharyngioma.
Hermann L Müller, Angela Emser, Andreas Faldum, Gina Bruhnken, Nicole Etavard-Gorris, Ursel Gebhardt, Rudolf Oeverink, Reinhard Kolb, Niels Sörensen. J Clin Endocrinol Metab 2004
163
25


Perioperative dexamethasone treatment in childhood craniopharyngioma--influence on short-term and long-term weight gain.
H L Müller, M Heinrich, K Bueb, N Etavard-Gorris, U Gebhardt, R Kolb, N Sörensen. Exp Clin Endocrinol Diabetes 2003
42
25

Octreotide therapy of pediatric hypothalamic obesity: a double-blind, placebo-controlled trial.
Robert H Lustig, Pamela S Hinds, Karen Ringwald-Smith, Robbin K Christensen, Sue C Kaste, Randi E Schreiber, Shesh N Rai, Shelly Y Lensing, Shengjie Wu, Xiaoping Xiong. J Clin Endocrinol Metab 2003
184
25

Mammillothalamic Disconnection Alters Hippocampocortical Oscillatory Activity and Microstructure: Implications for Diencephalic Amnesia.
Christopher M Dillingham, Michal M Milczarek, James C Perry, Bethany E Frost, Greg D Parker, Yaniv Assaf, Frank Sengpiel, Shane M O'Mara, Seralynne D Vann. J Neurosci 2019
17
25

Glucagon-like peptide-1 receptor is involved in learning and neuroprotection.
Matthew J During, Lei Cao, David S Zuzga, Jeremy S Francis, Helen L Fitzsimons, Xiangyang Jiao, Ross J Bland, Matthias Klugmann, William A Banks, Daniel J Drucker,[...]. Nat Med 2003
559
25

Blockade of NMDA or NO in the dorsal premammillary nucleus attenuates defensive behaviors.
Daniele Cristina Aguiar, Francisco Silveira Guimarães. Physiol Behav 2011
12
25

Axonal projections from the parasubthalamic nucleus.
Marina Goto, Larry W Swanson. J Comp Neurol 2004
58
25

LIM homeobox protein 5 (Lhx5) is essential for mamillary body development.
Amaya Miquelajáuregui, Teresa Sandoval-Schaefer, Miriam Martínez-Armenta, Leonor Pérez-Martínez, Alfonso Cárabez, Yangu Zhao, Michael Heide, Gonzalo Alvarez-Bolado, Alfredo Varela-Echavarría. Front Neuroanat 2015
5
25



Olfactory projections to the hypothalamus.
J L Price, B M Slotnick, M F Revial. J Comp Neurol 1991
128
25




A Paranigral VTA Nociceptin Circuit that Constrains Motivation for Reward.
Kyle E Parker, Christian E Pedersen, Adrian M Gomez, Skylar M Spangler, Marie C Walicki, Shelley Y Feng, Sarah L Stewart, James M Otis, Ream Al-Hasani, Jordan G McCall,[...]. Cell 2019
27
25

Projections of the ventral premammillary nucleus.
N S Canteras, R B Simerly, L W Swanson. J Comp Neurol 1992
136
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.